Avalon GloboCare Corp. (NASDAQ:ALBT) Sees Significant Decrease in Short Interest

Avalon GloboCare Corp. (NASDAQ:ALBT) was the recipient of a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 23,800 shares, a drop of 47.6% from the February 28th total of 45,400 shares. Approximately 5.6% of the shares of the company are sold short. Based on an average daily trading volume, of 86,600 shares, the days-to-cover ratio is presently 0.3 days.

Avalon GloboCare Stock Down 0.9 %

ALBT opened at $5.27 on Friday. The firm has a market cap of $5.77 million, a price-to-earnings ratio of -0.26 and a beta of -0.10. Avalon GloboCare has a 52 week low of $2.11 and a 52 week high of $21.60. The business’s 50 day moving average is $5.12 and its two-hundred day moving average is $3.94.

Avalon GloboCare Company Profile

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.